ライフサイエンスコーパス: vena cava

1 femoral vein through the adjoining inferior vena cava.

2 (n = 4) and C57BL/6 mice (n = 5), using the vena cava.

3 ha protein in TD compared with the aorta and vena cava.

4 bcostal four chamber, and subcostal inferior vena cava.

5 part of the right lung entering the superior vena cava.

6 eric arterioles, or ligation of the inferior vena cava.

7 , the left atrial appendage and the superior vena cava.

8 s in the right ventricular apex and superior vena cava.

9 luster between the right atrium and superior vena cava.

10 partial ligation (stenosis) of the inferior vena cava.

11 luding filter migration or thrombosis of the vena cava.

12 Robin sequence, and persistent left superior vena cava.

13 increased thrombus frequency in the inferior vena cava.

14 isolated and severed at the junction to the vena cava.

15 terminalis, RA free wall, and right superior vena cava.

16 d inside the coronary sinus via the superior vena cava.

17 ction, RV size, and dilation of the inferior vena cava.

18 t infusion of [14C]lactate into the inferior vena cava.

19 creating a lesion extending to the inferior vena cava.

20 pport for cannulation of the swine aorta and vena cava.

21 y artery=26, pulmonary vein=21, and superior vena cava=12).

22 rominent, including persistent left superior vena cava (13%) and partial anomalous pulmonary venous r

23 ); ascending aorta, 191 (121, 261); superior vena cava, 137 (77, 197); ductus arteriosus, 187 (109, 2

24 iosus (16/47, 34%), persistent left superior vena cava (14/47, 30%), and abnormal branching of the ri

25 ansected in a plane parallel to the inferior vena cava, (2) relocation of the incision for open divis

26 re (17 +/- 2%), thorax (14 +/- 2%), inferior vena cava (23 +/- 2%) and liver (23 +/- 2%) (all P </= 0

27 68); ascending aorta, 41 (29, 53); superior vena cava, 29 (15, 43); ductus arteriosus, 41 (25, 57);

28 n the descending thoracic aorta and inferior vena cava, a flow probe around the proximal left circumf

29 RP was achieved by cannulating the aorta and vena cava after death.

30 right phrenic nerve pacing from the superior vena cava, all patients underwent diaphragmatic electrom

31 comas that most commonly affect the inferior vena cava and account for 5% of all leiomyosarcomas.

32 For the superior vena cava and brachiocephalic veins, the reconstructions

33 facts limited the evaluation of the inferior vena cava and common iliac veins near the confluence.

34 150 mm Hg for 30 mins with VB drawn from the vena cava and delivered by an extracorporeal pump system

35 e into the left subclavian vein and superior vena cava and evaluated for up to 90 minutes.

36 of the adrenal vein drainage to the inferior vena cava and hepatic vein or of the inferior phrenic ve

37 pressor treatment by evaluating the inferior vena cava and other cardiac structures.Lung ultrasound c

38 portal vein, and hepatic vein) and infusion (vena cava and portal vein) catheters and flow probes (he

39 ed-chest, large-vessel anastomosis (superior vena cava and pulmonary artery [PA] or bidirectional Gle

40 transient balloon occlusion of the inferior vena cava and pulmonary artery, respectively.

41 vant (>3 mm) apposition between the inferior vena cava and pulmonary venous atrium (cavoatrial overla

42 ugh a region of overlap between the inferior vena cava and pulmonary venous atrium is feasible.

43 asure T1 of blood in the infrarenal inferior vena cava and renal veins after intravenous administrati

44 avascular balloon positioned at the superior vena cava and right atrial junction (SVC-RAJ) reduces so

45 tracer bolus dispersion in blood between the vena cava and the arterial tree was applied.

46 th a transformation that linked the superior vena cava and the coronary sinus from the CT model with

47 Similarly, the superior vena cava and the coronary sinus were also reconstructed

48 Tumors invading the vena cava and/or the hepatocaval confluence are indicati

49 platelet deposition in the ligated inferior vena cava, and diminished platelet activation in vitro.

50 right coronary artery (RCA) to the inferior vena cava, and from the RCA to the tricuspid valve annul

51 y of the abdomen, heart, chest, and inferior vena cava, and many variations in technique, protocols,

52 es, septal defects, persistent left superior vena cava, and patent ductus arteriosus, were present in

53 d during transient occlusion of the inferior vena cava, and repeat measurements were made after 1 (n=

54 itonin perfusion into the portal or inferior vena cava, and was confirmed by histological evaluations

55 induced by flow restriction in the inferior vena cava, APP-KO mice, as well as chimeric mice with se

56 ualized unequivocally in the murine inferior vena cava as hot spots in vivo by simultaneous acquisiti

57 icle cavity, left atrial cavity, or inferior vena cava as the IDIF.

58 re was a 17% difference in the image-derived vena cava blood activity at 60 min, compared with the ex

59 3%-100%), whereas 55% +/- 19 of the inferior vena cava blood flowed to the left PA (range, 22%-82%).

60 ntan circulation, 87% +/- 13 of the superior vena cava blood flowed to the right PA (range, 63%-100%)

61 KG-Ibeta isoform expressed equally in TD and vena cava, both being approximately 2 times higher than

62 passage of peak activity was observed in the vena cava, but the area under the curve over 2 min was s

63 esection with reconstruction of the inferior vena cava can be performed in selected cases.

64 rt hepatic vein dissection, and the inferior vena cava can be preserved, which provides advantages fo

65 at a rate of 1-2 L/min, with drainage of the vena cava, can achieve deep to profound hypothermia of v

66 Superior vena cava catheterization interventions between August 1

67 osity measures, pulse generator and superior vena cava coil location, and angle of lead exit from the

68 nfidence interval 0.65-0.89) or the inferior vena cava collapsibility index (area under the curve 0.6

69 us pressure (R = 0.58), whereas the inferior vena cava collapsibility index and the internal jugular

70 cators, with a significantly higher inferior vena cava collapsibility index on day 0 than nonacidotic

71 of central venous pressure than the inferior vena cava collapsibility index or the internal jugular v

72 Inferior vena cava collapsibility index was not an independent pr

73 , low stroke volume index, and high inferior vena cava collapsibility index, which improved with subs

74 or contractility and assessment of inferior vena cava collapsibility.

75 present a unique case, in which the inferior vena cava compression by a total artificial heart was in

76 The average distance to the RHV-inferior vena cava confluence was 28.7 mm.

77 re available in 65 patients, as the inferior vena cava could not be visualized in two patients.

78 he junction of the right atrium and superior vena cava, crista terminalis, tricuspid valve isthmus, c

79 Transmural pressure of the superior vena cava decreased during inspiration, whereas the tran

80 t between the right portal vein and inferior vena cava detected on postnatal ultrasound examination.

81 An inferior vena cava diameter < 2 cm predicted a central venous pre

82 pressure (< 10 mm Hg) was 0.91 for inferior vena cava diameter (95% confidence interval 0.84-0.98),

83 ransesophageal echocardiography, of inferior vena cava diameter (IVC) measured using transthoracic ec

84 ve study, respiratory variations of superior vena cava diameter (SVC) measured using transesophageal

85 The maximal inferior vena cava diameter correlated moderately with central ve

86 venous pressure after adjusting for inferior vena cava diameter in a multiple linear regression model

87 ut vasopressor support, the maximal inferior vena cava diameter is a more robust estimate of central

88 Respiratory variation in vena cava diameter measured by ultrasound (distensibilit

89 The proximal mouse vena cava diameter was 2.54 +/- 0.30 mm.

90 to width ratio (aspect ratio), the inferior vena cava diameter, and the percent collapse of the infe

91 ment of the central isthmus (RCA to inferior vena cava distance).

92 Patients with less vena cava distensibility were not as likely to be fluid

93 The collapsibility index of the inferior vena cava during a deep standardized inspiration is a si

94 ted into the grafts through the suprahepatic vena cava during cold storage (VSOP-NO group; n=20).

95 ortened because it hides behind the inferior vena cava during laparoscopic transperitoneal dissection

96 ential expression pattern in mouse aorta vs. vena cava ECs, which cannot be explained by the differen

97 An active can coupled to the superior vena cava electrode served as the return for the RV and

98 s when they become firmly embedded along the vena cava endothelium.

99 Vena cava filter (VCF) placement for pulmonary embolism

100 verity were assigned to retrievable inferior vena cava filter implantation plus anticoagulation (filt

101 Insertion of a retrievable inferior vena cava filter in patients randomized to the filter gr

102 d with a significant bleeding risk, inferior vena cava filter insertion compared with anticoagulant t

103 we assessed the association between inferior vena cava filter insertion for known significant bleedin

104 surgical pulmonary embolectomy, and inferior vena cava filter insertion.

105 Trauma patients and inferior vena cava filter placements were excluded.

106 embolism, the use of a retrievable inferior vena cava filter plus anticoagulation compared with anti

107 r thrombosis risk factors, avoiding inferior vena cava filter usage except in specified circumstances

108 The effectiveness of inferior vena cava filter use among patients with acute symptomat

109 lism (previous thromboembolism, preoperative vena cava filter, hypoventilation, pulmonary hypertensio

110 heparin (29%), dalteparin (40%), or inferior vena cava filters (20%) were not statistically different

111 ), thrombolytic drugs (3 patients), inferior vena cava filters (3 patients) and, eventually, warfarin

112 Evidence that vena cava filters (VCFs) are beneficial is limited.

113 change in the society guidelines, the use of vena cava filters (VCFs) continues to rise.

114 Although retrievable inferior vena cava filters are frequently used in addition to ant

115 Limited evidence suggests that vena cava filters are only modestly efficacious for prev

116 erventions such as thrombolysis and inferior vena cava filters are reserved for limited circumstances

117 aim to define prolonged retrievable inferior vena cava filters dwell time by determining the inflecti

118 However, mechanical approaches such as vena cava filters have high complication and treatment f

119 investigate the survival effects of inferior vena cava filters in patients with venous thromboembolis

120 Patients with retrievable inferior vena cava filters in place beyond 7 months may benefit f

121 Although chronically implanted inferior vena cava filters may result in filter-related morbidity

122 inform the management of fractured inferior vena cava filters on the basis of results from a tertiar

123 l is effective in removing embedded inferior vena cava filters refractory to standard retrieval and h

124 Superior vena cava filters should be avoided.

125 The use of prophylactic vena cava filters should be re-examined.

126 Until further data emerge, thrombolysis and vena cava filters should be reserved for patients in who

127 Vena cava filters were placed in 3,883 patients, 86% as

128 Inferior vena cava filters were placed in 46%.

129 y impacted retrieval of retrievable inferior vena cava filters with prolonged dwell times; however, t

130 g, feeding tube placement, tracheostomy, and vena cava filters) among nursing home residents to rates

131 d efficacy of thrombolytic therapy, inferior vena cava filters, and embolectomy during pregnancy.

132 is is best reserved for severe VTE; inferior vena cava filters, ideally the retrievable variety, shou

133 growth in placement of retrievable inferior vena cava filters, retrieval rates remain low.

134 be diminished by leg compression devices or vena cava filters.

135 t of enteral feeding tubes, and insertion of vena cava filters.

136 gulation may be more effective than inferior vena cava filtration devices for treating venous thrombo

137 e flow were performed by increasing inferior vena cava flow.

138 trial fibrillation triggered from a superior vena cava focus (1 patient) adjacent to the right PN or

139 combined resection of the liver and inferior vena cava for hepatic malignancy.

140 embolism (five of 23; 22%), and the inferior vena cava (four of 23; 17%).

141 t anastomosis of liver allograft to a Dacron vena cava graft can be a feasible solution if traditiona

142 ing (index of collapsibility of the superior vena cava>/=36%), inotropic support (left ventricular fr

143 Involvement of the inferior vena cava has traditionally been considered a contraindi

144 lum and the posterior margin of the inferior vena cava (hilar-caval line) on lateral radiographs; thi

145 rombosis created by ligation of the inferior vena cava, HO-1 expression is markedly induced.

146 Following ligation of the inferior vena cava, HO-1(-/-) mice exhibited increased nuclear fa

147 Powder; n = 7) or infusion into the inferior vena cava (Humulin R; n = 6) using an algorithm to match

148 Vena cava IDIF (n = 7) was compared with the left ventri

149 after acute insulin treatment, using a mouse vena cava IDIF approach.

150 The mouse vena cava IDIF provides repeatable assessment of the blo

151 ardial glucose uptake rates (rMGU) using the vena cava IDIF were calculated at baseline (n = 8), afte

152 ne of the following severe injuries: aortic, vena cava, iliac vessels, cardiac, grade IV/V liver inju

153 alysis was systematically assessed using the vena cava image-derived blood input function (IDIF).

154 en, kidney, brain, lung, vitreous humor, and vena cava in comparison to untreated controls (P </= .05

155 scle tissues, such as the aorta and inferior vena cava, in which Mypt1 E23 is predominately skipped.

156 thrombosis induced by flow reduction in the vena cava inferior, we identified blood-derived high-mob

157 geometry and flow rates through the superior vena cava, inferior vena cava, left pulmonary artery, an

158 We hypothesize that inferior vena cava-inferior atrial ganglionated plexus nerve acti

159 odegradable TEVGs were implanted as inferior vena cava interposition conduits in 2 groups of C57BL/6

160 s that were surgically implanted as inferior vena cava interposition grafts in SCID/bg mice.

161 nctive therapeutic modalities (thrombolysis, vena cava interruption, venous stenting).

162 Persistent left superior vena cava is a rare but important congenital vascular an

163 on across endothelium obtained from inferior vena cava is CD18-dependent.

164 Additionally, the transmural pressure of the vena cava is decreased, whereas the transmural pressure

165 us oxygen saturation (ScvO2) in the superior vena cava is predominantly determined by cardiac output,

166 Adjunctive ablation included superior vena cava isolation in 6 patients, cavotricuspid isthmus

167 l treatment of chronic occlusion of inferior vena cava (IVC) and iliocaval confluence with angioplast

168 with incidental finding of complete inferior vena cava (IVC) and obliteration.

169 iepsilonRACK (1.5 nmol) through the inferior vena cava (IVC) and subsequently submerged in psiepsilon

170 ng the IPVE, and using the aorta or inferior vena cava (IVC) as the input function.

171 e inside diameters of the aorta and inferior vena cava (IVC) at the top of L2 and the bottom of L4 an

172 Failure to remove a retrievable inferior vena cava (IVC) filter can cause severe complications wi

173 after implantation of an absorbable inferior vena cava (IVC) filter in a swine model.

174 erlapping heparin and warfarin, and inferior vena cava (IVC) filter placement were not independent pr

175 e relationship between prophylactic inferior vena cava (IVC) filter use, mortality, and VTE.

176 Inferior vena cava (IVC) filters are widely used for prevention o

177 The use of inferior vena cava (IVC) filters for prevention of venous thrombo

178 The use of inferior vena cava (IVC) filters in this population has been incr

179 divided on the role of prophylactic inferior vena cava (IVC) filters to prevent PE.

180 se of anticoagulation, placement of inferior vena cava (IVC) filters, clinical outcomes, and comments

181 ecent studies concerning the use of inferior vena cava (IVC) filters.

182 lower loop reentry (LLR) around the inferior vena cava (IVC) has been described recently.

183 unseeded control) were implanted as inferior vena cava (IVC) interposition grafts in juvenile lambs.

184 Obstruction of the inferior vena cava (IVC) is infrequent, membranous obstruction of

185 (WT) littermates underwent partial inferior vena cava (IVC) ligation to induce venous thrombosis.

186 hat 48-hour flow restriction in the inferior vena cava (IVC) results in the development of thrombi st

187 Here, using a murine DVT model of inferior vena cava (IVC) stenosis, we demonstrate that mice with

188 Inferior vena cava (IVC) thrombosis is generally a contraindicati

189 nt of chronic iliofemoral (I-F) and inferior vena cava (IVC) thrombosis.

190 er is associated with renal vein or inferior vena cava (IVC) thrombus in up to 10% of cases.

191 PV access from the inferior vena cava (IVC) to the main PV was performed in eight pi

192 t has been suggested for the use of inferior vena cava (IVC) value instead of FHVP to calculate HVPG

193 ption of the hepatic segment of the inferior vena cava (IVC) were the vascular anomalies.

194 onal profile of the mouse aorta and inferior vena cava (IVC), not restricting our analysis to the end

195 resection and reconstruction of the inferior vena cava (IVC), were reviewed.

196 Ten inferior vena cava (IVC)-SMV punctures were performed in six pigs

197 ging tumors with extension into the inferior vena cava (IVC).

198 ccluded iliofemoral veins (IFV) and inferior vena cava (IVC).

199 ) and infrahepatic and suprahepatic inferior vena cava (IVC).

200 tes through the superior vena cava, inferior vena cava, left pulmonary artery, and right pulmonary ar

201 Baseline renal vein and inferior vena cava levels of inflammatory markers were measured a

202 tibility to venous thrombosis after inferior vena cava ligation at 12 or 18 months of age (P<0.05 ver

203 tion after carotid artery injury or inferior vena cava ligation.

204 decrease the theoretical risk of a positive vena cava margin or hematologic metastases.

205 thromboses, including those in the inferior vena cava (n = 10), portal and superior mesenteric veins

206 tion of the mesentericoportal vein (n = 24), vena cava (n = 3), or hepatic vein (n = 3).

207 Inferior vena cava occlusion at all experimental stages (baseline

208 temporary preload reduction during inferior vena cava occlusion initially induced an expansion of LV

209 erior vena cava thrombosis, chronic inferior vena cava occlusion, and pain from retroperitoneal or bo

210 ume loop data obtained during acute inferior vena cava occlusion.

211 Venous thrombosis was induced in the vena cava of BALB/C mice, and temporal changes in T1 rel

212 vein thrombosis was induced in the inferior vena cava of male BALB/C mice.

213 nt platelet microparticles into the inferior vena cava of mice and harvested endothelial cells from t

214 Injection of NbE-1 cells into the inferior vena cava of syngeneic rats indicated that these cells a

215 sside nor blood withdrawal from the superior vena cava or carotid artery elicited USV from pups in th

216 scular reconstruction of either the inferior vena cava or hepatic veins was performed in five patient

217 Despite significant inferior vena cava or hepatic venous compression in 65%, hepatic

218 n, 18 kg) kg of whom 4 had occluded inferior vena cava or iliac veins and 2 had previous complex vasc

219 tion of a roughened catheter into either the vena cava or the aorta.

220 llate ganglia; (3) occlusion of the inferior vena cava or thoracic aorta; (4) transient ventricular i

221 vant index of collapsibility of the superior vena cava), or increased vasopressor support (right vent

222 chian ridge, crista terminalis, and superior vena cava); or arm 3, standard approach + ablation of le

223 triotomy to the inferior vena cava, superior vena cava, or tricuspid annulus or by ablating focally i

224 ent strategies including continuous superior vena cava oximetry (SvO2), phenoxybenzamine (POB), strat

225 id resuscitation and fluid removal, superior vena cava oxygen saturation, goal-directed, coagulation,

226 ed as the lower of the superior and inferior vena cava oxygen saturations.

227 ; P=0.005), whereas persistent left superior vena cava (P=0.85), ventricular septal defect (P=0.12),

228 ocardium in late frames as compared with the vena cava (percentage injected dose per gram, ctl: 21.4+

229 Vena cava pertinent diameters were measured 15-20 mm cau

230 thy through partial ligation of the inferior vena cava (pIVCL).

231 t on a rare case of persistent left superior vena cava (PLSVC) with absent right superior vena cava (

232 ed with extensive thromboses of the inferior vena cava, portal vein, and hepatic veins, was successfu

233 ne subject, a congenital left-sided superior vena cava precluded right-sided capture.

234 , patients had significantly higher inferior vena cava pressures (15.6 versus 13.7 mm Hg; P=0.007), b

235 constructed or reimplanted into the inferior vena cava primarily (n = 8) or using segments of the por

236 hout partial-volume correction, the inferior vena cava provides a reliable and reproducible IDIF for

237 her the collapsibility index of the inferior vena cava recorded during a deep standardized inspiratio

238 computer modeling was used to determine the vena cava recovery coefficient.

239 Cerebral cortex, tympanic membrane, inferior vena cava, rectal temperatures, electrocardiogram, arter

240 Superior vena cava-related symptoms occur in only 50% of patients

241 e usefulness of respiratory variation in the vena cava requires confirmatory studies.

242 stomosed to the abdominal aorta and inferior vena cava, respectively, of the (splenectomized) recipie

243 o the recipient abdominal aorta and inferior vena cava, respectively.

244 ant differences in pressure between inferior vena cava, right atrium, and left atrium were found.

245 After catheterization of the inferior vena cava, right atrium, foramen ovale, and left atrium

246 Aortic or superior vena cava rim deficiencies were more common in cases tha

247 vena cava (PLSVC) with absent right superior vena cava (RSVC).

248 The presented IDIF from the vena cava showed a robust determination of CMRGlc using

249 ach]; the lowest proportion was for inferior vena cava size [75%]).

250 unted for (aortic valve was 91% and inferior vena cava size was 58%).

251 (aortic valve was 96% [highest] and inferior vena cava size was 78% [lowest]) and decreased when nonv

252 When adjusted for age, LVEF, inferior vena cava size, and RV size and function, survival was w

253 A young woman with a benign superior vena cava stenosis due to a tunneled internal jugular ve

254 umor-bearing and control mice in an inferior vena cava stenosis model.

255 mice produced a thrombus 48 h after inferior vena cava stenosis whereas 90% of wild-type mice did.

256 hrough at the junction of the right superior vena cava, sulcus terminalis, and RA free wall, correspo

257 n from the lateral atriotomy to the inferior vena cava, superior vena cava, or tricuspid annulus or b

258 (PV) origin, those arising from the superior vena cava (SVC) can precipitate atrial fibrillation (AF)

259 PURPOSE OF REVIEW: Superior vena cava (SVC) is one of the most important nonpulmonar

260 estigate the causes and symptoms of superior vena cava (SVC) obstruction or occlusion and report on t

261 ntral veins of the thorax including superior vena cava (SVC), brachiocephalic (BCV), subclavian (SCV)

262 if they resided anywhere within the superior vena cava (SVC).

263 lt from vascular obstruction of the superior vena cava (SVC).

264 Specifically, superior vena cava syndrome may warrant radiation, chemotherapy,

265 Superior vena cava syndrome was more common in the non-cardiac su

266 ogy department with symptoms of the superior vena cava syndrome.

267 n into aorto-iliac/visceral arteries and the vena cava (temporal resolution, five images per second;

268 atlak slope was significantly higher for the vena cava than atrial IDIF (mL/g/min, ctl: 0.11+/-0.02 v

269 a principal discharge diagnosis of inferior vena cava thrombosis (International Classification of Di

270 Vena cava thrombosis can represent a surgical challenge

271 T in the treatment of patients with inferior vena cava thrombosis in the United States.

272 ombolysis (CDT) in the treatment of inferior vena cava thrombosis is unknown.

273 Among 2674 patients admitted with inferior vena cava thrombosis, 718 (26.9%) underwent CDT.

274 tions included filter-related acute inferior vena cava thrombosis, chronic inferior vena cava occlusi

275 r cardiopulmonary bypass because of extended vena cava thrombosis; in 2 patients, a simultaneous ster

276 rom the right or left lung into the inferior vena cava, through drainage into the hepatic vein, right

277 The vena cava time-activity curve is therefore a minimally i

278 lation of a balloon catheter in the inferior vena cava to identify the lower limit of cerebral autore

279 eter positioned in the retrohepatic inferior vena cava to shunt hepatic venous effluent through an ac

280 Puncture through the inferior vena cava to the pulmonary venous atrium may be an effec

281 nonsurgical crossing from a donor (superior vena cava) to a recipient (PA) vessel and endovascular s

282 Mouse inferior vena cava-to-carotid interposition isografts were comple

283 dex and collapsibility index of the inferior vena cava under a deep standardized inspiration using tr

284 ng recipient hepatectomy rendered the native vena cava unsalvageable.

285 fraction, mitral regurgitation, and inferior vena cava variability) and correlated abnormalities in s

286 and recruitment of platelets to the inferior vena cava wall after DVT induction were reduced in MC-de

287 poE-null mice in which a segment of inferior vena cava was grafted into the right carotid artery at 1

288 PVs plus empirical isolation of the superior vena cava was performed in all.

289 ic coarctation, and persistent left superior vena cava was significantly associated with women with T

290 In addition, the donor vena cava was too short to bridge the caval defect for i

291 iced, the catheter, access vein, and cranial vena cava were dissected, removed en bloc, and fixed in

292 l four pulmonary vein antra and the superior vena cava were isolated using an ICE-guided technique.

293 he left atrium, coronary sinus, and superior vena cava were targeted for ablation.

294 All pulmonary veins, including the superior vena cava, were successfully isolated.

295 alignment defects, and interrupted inferior vena cava with azygos continuation.

296 ided gallbladder and an interrupted inferior vena cava with azygous continuation.

297 er, and the percent collapse of the inferior vena cava with inspiration (collapsibility index) by ult

298 s produced enhanced uptake of virions in the vena cava with selective transgene expression.

299 f chronic indwelling CVC in the low superior vena cava with thrombus in situ was established after fe

300 with a flattened right lobar portal vein and vena cava without any visible active bleeding.